X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (247) 247
Publication (30) 30
Conference Proceeding (9) 9
Newspaper Article (3) 3
Book Review (2) 2
Paper (1) 1
Streaming Audio (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (89) 89
index medicus (77) 77
female (69) 69
middle aged (69) 69
male (68) 68
adult (63) 63
oncology (52) 52
aged (51) 51
hematology (46) 46
antineoplastic combined chemotherapy protocols - therapeutic use (31) 31
aged, 80 and over (28) 28
chemotherapy (26) 26
treatment outcome (25) 25
therapy (24) 24
cancer (23) 23
disease-free survival (22) 22
lymphomas (22) 22
adolescent (21) 21
non-hodgkins-lymphoma (21) 21
prognosis (21) 21
rituximab (19) 19
lymphoma (18) 18
neoplasm staging (18) 18
transplantation (18) 18
diagnosis (16) 16
abridged index medicus (15) 15
young adult (15) 15
clinical trials (14) 14
cyclophosphamide (14) 14
internal medicine (14) 14
care and treatment (13) 13
immunochemotherapy (13) 13
mantle cell lymphoma (13) 13
medicine & public health (13) 13
risk factors (13) 13
survival (13) 13
tumors (13) 13
analysis (12) 12
antineoplastic combined chemotherapy protocols - administration & dosage (12) 12
article (12) 12
combined modality therapy (12) 12
cyclophosphamide - administration & dosage (12) 12
hemic and lymphatic diseases (12) 12
antineoplastic agents - therapeutic use (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
chronic lymphocytic-leukemia (11) 11
follow-up studies (11) 11
pathology (11) 11
survival analysis (11) 11
vincristine - administration & dosage (11) 11
doxorubicin - administration & dosage (10) 10
expression (10) 10
follicular lymphoma (10) 10
radiotherapy (10) 10
cyclophosphamide - therapeutic use (9) 9
disease (9) 9
flow cytometry (9) 9
hematology, oncology and palliative medicine (9) 9
hodgkin lymphoma (9) 9
medicine, general & internal (9) 9
multicenter (9) 9
multiple myeloma (9) 9
prednisone - administration & dosage (9) 9
recurrence (9) 9
relapse (9) 9
stem cells (9) 9
survival rate (9) 9
trial (9) 9
antibodies, monoclonal, murine-derived - administration & dosage (8) 8
antibodies, monoclonal, murine-derived - therapeutic use (8) 8
antineoplastic agents - administration & dosage (8) 8
b-cell lymphoma (8) 8
combination (8) 8
doxorubicin (8) 8
hodgkin disease - drug therapy (8) 8
immunology (8) 8
immunotherapy (8) 8
kaplan-meier estimate (8) 8
leukemia (8) 8
lymphoma, follicular - drug therapy (8) 8
medical colleges (8) 8
prospective studies (8) 8
retrospective studies (8) 8
cancer therapies (7) 7
colony-stimulating factor (7) 7
health aspects (7) 7
high-dose chemotherapy (7) 7
immune system diseases (7) 7
immunophenotyping (7) 7
medical and health sciences (7) 7
medicin och hälsovetenskap (7) 7
prednisone - therapeutic use (7) 7
research (7) 7
time factors (7) 7
transplantation, autologous (7) 7
vincristine - therapeutic use (7) 7
bone-marrow-transplantation (6) 6
brentuximab vedotin (6) 6
diseases (6) 6
elderly-patients (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10094, pp. 555 - 566
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9980, pp. 1853 - 1862
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 11, pp. 1013 - 1022
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 4, pp. 424 - 435
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10044, pp. 565 - 575
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2007, Volume 357, Issue 19, pp. 1916 - 1927
Journal Article
British Journal of Haematology, ISSN 0007-1048, 11/2018, Volume 183, Issue 3, pp. 400 - 410
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 319 - 331
Journal Article
Nowotwory, ISSN 0029-540X, 2015, Volume 65, Issue 6, pp. 529 - 534
Journal Article
Molecular Physics, ISSN 0026-8976, 07/2014, Volume 112, Issue 14, pp. 1835 - 1836
  Molecular Physics Longuet-Higgins Young Author's Prize 2013 winner profile 
Journal Article
Modern Pathology, ISSN 0893-3952, 05/2018, Volume 31, Issue 5, pp. 732 - 743
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 01/2018, Volume 378, Issue 4, pp. 331 - 344
BACKGROUND Brentuximab vedotin is an anti-CD30 antibody-drug conjugate that has been approved for relapsed and refractory Hodgkin's lymphoma. METHODS We... 
TRIAL | ABVD | MEDICINE, GENERAL & INTERNAL | POSITRON-EMISSION-TOMOGRAPHY | RESPONSE CRITERIA | DISEASE | PROGNOSTIC SCORE | OPEN-LABEL | TOXICITY | INTERGROUP | COOPERATIVE-ONCOLOGY-GROUP | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - administration & dosage | Immunoconjugates - administration & dosage | Young Adult | Aged, 80 and over | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Neutropenia - chemically induced | Doxorubicin - administration & dosage | Immunoconjugates - adverse effects | Dacarbazine - administration & dosage | Immunologic Factors - administration & dosage | Survival Rate | Bleomycin - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Aged | Immunologic Factors - adverse effects | Neoplasm Staging | Vinblastine | Hematology | Toxicity | Prophylaxis | Clinical trials | Oncology | Peripheral neuropathy | Cancer therapies | Doxorubicin | Survival | Lymphoma | Medicine | Dacarbazine | Chemotherapy | Bleomycin | CD30 antigen | Granulocyte colony-stimulating factor | Death | Colony-stimulating factor | Lymphomas | Leukocytes (granulocytic) | Drug dosages | Hodgkin's disease | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article